查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853253

醫用導管市場：按材料、最終用途、製造流程、產品類型和最終用戶分類－2025-2032年全球預測

Medical Tubing Market by Material, End Use, Manufacturing Process, Product Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫用導管市場規模將達到 193.3 億美元，複合年成長率為 12.18%。

關鍵市場統計數據
基準年 2024 77億美元
預計年份：2025年 86.3億美元
預測年份 2032 193.3億美元
複合年成長率 (%) 12.18%

全面檢視醫用導管的最新趨勢，重點放在臨床需求促進因素、材料演變和跨職能優先事項。

醫用導管在眾多臨床介入措施中發揮著至關重要的作用，它不僅是醫療設備安全性、易用性和治療效果的關鍵技術推動因素，也是其差異化優勢所在。手術量的不斷成長、患者舒適度期望的提高以及微創手術的普及，都推動了對兼具柔韌性、生物相容性和可製造性的導管的需求持續成長。聚合物科學的進步正在研發出能夠延長導管使用壽命、降低血栓形成風險並支持新型黏合技術的混合物和配方，而新的表面處理技術則提高了導管的潤滑性和藥物釋放型能力。這些材料方面的進步與製造技術的創新相融合，精密擠出和雷射焊接等工藝正在塑造產品的形狀和公差。

法律規範和臨床證據要求持續對產品設計和供應商選擇產生重大影響，促使製造商投資於能夠滿足可追溯性、供應商合格和嚴格品質系統要求的實踐。同時，由於全球動盪和貿易政策的轉變，供應鏈韌性已成為企業高層關注的焦點。因此，策略性相關人員必須協調近期業務需求與長期研發投入，以確保導管解決方案符合臨床醫師的需求、病人安全和成本效益目標。本文為處於轉型期的這個產業提供了一個框架，其中臨床需求、材料創新、監管嚴格性和供應鏈策略的整合將決定競爭優勢。

分析影響醫用導管市場的變革性變化，包括技術、監管和臨床曲折點。

受多種因素影響，醫用導管市場正經歷結構性變革。聚合物化學和加工技術的進步推動了具有更優異生物相容性、機械性能和耐滅菌性能的導管的研發。這些創新使得更薄壁結構、多腔設計和雷射焊接接頭成為可能，從而促進了微創手術和更複雜器械的組裝。同時，從線上品質檢測到數據主導的製程控制，製造流程的數位化提高了產品的重複性，減少了廢品，使製造商能夠滿足更嚴格的公差要求，並加快新產品的上市速度。

監管機構的期望也在向更高的透明度和上市後監管方向轉變，促使醫療器材製造商和供應商加強對材料表徵、批次追溯和長期生物相容性測試的投入。居家醫療和門診手術的興起推動了對易用耐用導管的需求，而介入性心臟病學和眼科的發展則需要能夠在複雜機械應力下表現優異的專用材料。供應鏈策略也正在發生類似的轉變，企業正在實現供應商多元化，並將部分職能外包到近岸地區，以降低地緣政治和物流風險。這些變革性的轉變正在重新定義產品要求和商業模式，使那些兼具材料專業知識、工藝規範和監管應對力的供應商更具優勢。

評估美國於2025年宣布的關稅措施的累積影響，以及這些措施對醫用導管相關人員的營運、採購和策略影響。

2025年實施的關稅政策變化為醫用導管價值鏈的採購、製造和銷售策略引入了新的變數。對許多製造商而言，關稅增加了進口聚合物樹脂、特殊化合物和成品組件的到岸成本，改變了採購決策的考量。為此，採購團隊加快了供應商資格認證工作，優先考慮來自國內或免稅地區的替代樹脂等級，並重新評估總擁有成本，而不僅依賴單價比較。這些調整通常需要重新談判長期供應契約，並對關稅工程方案進行更深入的分析。

在營運方面，一些公司採取了雙源籌資策略，並增加了境內庫存緩衝，以降低成本突然波動帶來的風險。另一些公司則投資於臨床上可接受的材料替代項目，透過替代功能等效的聚合物來規避受關稅影響的供應鏈，並確保符合監管要求。在策略方面，關稅的實施使企業重新關注在關稅優惠地區內的垂直整合和產能擴張，促使企業將資金配置到更靠近終端市場的擠出工廠。同時，由於醫用導管組件的複雜分類會影響關稅的適用性，政策的轉變也凸顯了監管協調和海關專業知識的重要性。總體而言，關稅的累積效應是加速本地化進程，實現供應鏈多元化，並推動製造商建立更具韌性的採購結構，同時保持臨床性能和合規性。

整合材料科學、最終用途差異、製造方法、產品類型和最終用戶行為的關鍵細分洞察，指南策略重點。

材料選擇仍然是決定管材性能和監管途徑的關鍵因素。市面上提供聚乙烯、聚氨酯、聚氯乙烯、矽橡膠和熱可塑性橡膠，每種材料在柔韌性、耐化學性和滅菌相容性方面各有優劣。高密度聚乙烯和低密度聚乙烯的機械性質不同，可根據剛度和加工需求進行選擇。聚氨酯分為熱塑性聚氨酯和熱固性聚氨酯，二者在可加工性和抗疲勞性上有差異。聚氯乙烯包括用於結構部件的剛性聚氯乙烯和用於軟性應用的軟性聚氯乙烯。矽橡膠包括高黏度矽橡膠和液態矽橡膠，分別適用於不同的成型和擠出需求。熱可塑性橡膠包括烯烴類和苯乙烯類，兼具彈性和加工效率。了解這些材料差異對於將設備要求與可加工性和生命週期性能量相匹配至關重要。

依最終用途進行細分可以揭示臨床上的具體需求，因為導管、牙科、輸液、介入和眼科應用都需要不同的管材表現。在輸液應用中，又可進一步區分腸內輸液和靜脈輸液，每種輸液方式都有其獨特的安全性和相容性要求。血管成形術和置入術等介入領域則優先考慮抗扭結性、潤滑性和精確的尺寸控制。擠出成型製程可以實現連續的多腔管型，而模壓成型製程則可滿足複雜的連接器幾何形狀。按產品類型分類，我們提供導管管、擠出管和雷射焊接管。擠出管可進一步分為多腔管和單腔管，這會影響設備的複雜性和組裝。不同的最終用戶，例如門診醫療中心、診所、居家醫療和醫院，會影響需求模式、採購方式和服務水準預期。整合這些細分可以製定更準確的產品藍圖、供應商選擇和商業化策略，從而反映臨床效能要求和營運實際情況。

區域洞察報告重點分析各主要區域不同的需求促進因素、法規環境和供應鏈策略，以指南市場進入和擴張。

美洲地區持續佔據成熟的醫療器材市場，其特點是成本效益高的製造流程、嚴格的監管審查、先進的臨床應用以及醫院強大的採購能力。在該地區，報銷機制和集中採購會影響產品商業化進程，而靠近原料製造商和零件供應商則有利於複雜組件的組裝和快速原型製作。面向美洲市場的製造商通常會優先考慮完善的監管文件和供應鏈透明度，以滿足醫療系統採購流程的要求。

歐洲、中東和非洲的監管和市場格局複雜多樣，既有統一的標準，也有報銷和臨床實務的區域差異。歐洲市場強調永續性、延長產品生命週期和嚴格的臨床證據，而中東和非洲部分地區則更注重價格可負擔性和供應鏈的連續性。在這一複雜地區運作的公司受益於模組化的監管策略和擴充性的製造地能夠處理高度複雜且成本敏感的產品。

亞太地區正經歷著蓬勃發展，這主要得益於醫療基礎設施的不斷完善、門診服務的日益成長以及聚合物和零件製造基礎的不斷深化。在地化的供應鏈、具競爭力的人事費用以及不斷成長的國內需求，正推動區域產能和材料創新方面的投資。然而，各國的基礎設施和監管成熟度差異顯著，因此，成功的策略往往是將以出口為導向的營運與有針對性的本地合作相結合，以滿足特定的臨床和採購需求。在整個亞太地區，各公司都在調整策略，以平衡客戶接近性、關稅影響和監管合規性等因素。

關鍵的公司層面洞察，揭示供應鏈定位如何影響競爭動態、創新策略和市場領導潛力。

領先的供應商憑藉深厚的材料專業知識、完善的品質體係以及與監管機構合作的良好記錄脫穎而出。那些投資於特定應用研發並將聚合物科學轉化為臨床性能改進（例如降低血栓形成性和提高抗扭結性）的公司，往往更受醫療設備原始設備製造商 (OEM) 的青睞。管材專家與醫療設備製造商之間的策略夥伴關係能夠加快聯合開發週期並縮短檢驗時間，從而快速推出新一代管材解決方案。掌控上游配製和下游組裝環節的公司可以提供更具競爭力的前置作業時間和更嚴格的成本控制，這在受關稅波動和供應鏈中斷影響的環境中至關重要。

併購、策略性收購和產能擴張投資正在重塑供應商格局，使部分公司能夠拓展服務範圍，從客製化擠壓件到包含連接器和焊接介面的完整管材組件。專注於擠壓和雷射焊接的契約製造製造商提供靈活的生產模式，吸引那些希望在不投入巨額資本的情況下擴大規模的中型原始設備製造商 (OEM)。此外，預測性維護、線上檢測和數位化批次文件等數位化能力透過降低品質風險和加快監管申報速度，提升了供應商的價值提案。最終，競爭優勢將取決於技術差異化與可擴展營運、監管能力和以客戶為中心的服務模式的契合度。

為行業領導者提供切實可行的建議，以加強創新管道、確保供應連續性並最佳化監管和商業性路徑。

產業領導者應優先考慮那些既能降低營運風險又能實現產品差異化的投資。透過分級認證計畫和選擇性近岸外包來加強供應商網路，可以減輕關稅引起的成本波動的影響，同時保持對特種聚合物等級的取得。同時，加快材料替代舉措並輔以嚴格的檢驗通訊協定，可以靈活地從受限的樹脂系列中轉型，而不會影響臨床性能。從創新角度來看，跨職能團隊必須將研發與臨床相關人員緊密結合，以確保管材開發能夠應對實際手術操作中的挑戰，例如微創手術的微型化和介入器材的增強觸覺回饋。

領導者還應將上市後監測和完善的可追溯性納入產品生命週期，以實現監管前瞻性的製度化，簡化核准，並增強客戶信心。商業策略應將差異化技術優勢與服務水準承諾（例如縮短前置作業時間和可配置的物流）結合。最後，企業應評估選擇性垂直整合和策略夥伴關係，以保護淨利率並控制關鍵零件的質量，同時利用製造外包實現可擴展的大批量生產。這些綜合措施可以提高企業在多元化終端使用者管道中的韌性、加快產品上市速度並增強競爭優勢。

透過深入的調查方法，採用穩健的多源方法，結合一手檢驗、材料分析、製造流程圖譜繪製和法規審查，以獲得可靠的洞察。

檢驗調查方法，透過結合一手資料驗證、材料分析、製造流程梳理和法規審查等多源數據，以獲得可靠的研究見解。

調查方法結合了對技術文獻、標準和專利概況的全面回顧，以及對高級採購主管、研發負責人、法規專家和臨床終端用戶的結構化訪談。訪談提供了來自實際應用的觀點，包括材料性能權衡、供應商選擇標準以及關稅政策變化對營運的影響。材料分析比較評估了聚合物的性能、滅菌相容性和可製造性限制，以評估其在不同應用類型中的實際適用性。製造流程圖分析確定了擠出和成型製程的產能和產量特徵，並重點指出了雷射焊接可以整合到組裝流程中的環節。

監管審查重點在於影響管材認證時間的途徑考量、生物相容性測試預期以及文件規範。研究結果透過三角驗證法進行交叉驗證，將原始資訊與技術資訊來源和可觀察的商業活動進行匹配，以確保結論既反映經驗實踐，又反映技術現實。研究採用細分框架，將材料系列、最終用途、製造流程、產品類型和最終用戶管道映射到可操作的決策維度。品管包括專家同行檢驗和行業從業人員的迭代檢驗，以確保研究結果具有可操作性、可重複性，並與策略決策直接相關。

結論總結強調，需要將策略重點、風險緩解策略和創新與臨床和供應鏈的實際情況相協調。

總之，醫用導管領域既充滿機會又錯綜複雜，材料創新、製造精度、監管嚴格性和不斷變化的貿易政策在此交匯融合。能夠將材料科學與嚴謹的製造流程和合規性結合，同時又能有效規避地緣政治和關稅波動的企業，將擁有戰略優勢。最成功的企業將是那些能夠將臨床洞見轉化為精準的導管製造能力，並以高效的供應鏈支撐其創新成果，同時為終端用戶提供極具吸引力的總體成本和服務提案的企業。

在政策環境不斷變化的當下，透過投資多元化採購、材料靈活性和近期生產韌性來降低風險，對於維持業務連續性至關重要。同時，保持競爭力需要持續的研發投入，以滿足臨床醫生主導的性能要求以及不斷發展的滅菌和生物相容性標準。透過優先考慮這些策略槓桿，相關人員既可以應對短期挑戰，又能建立必要的基礎能力，從而在日益重視準確性、可靠性和臨床相關性的市場中創造長期價值。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 可依患者特定輸液需求量身訂做的生物相容性聚合物管路
  • 將抗菌塗層整合到醫用導管中，以減少院內感染。
  • 先進外科手術中對防扭結多腔導管的需求日益成長
  • 用於提高藥物傳輸化學惰性的無矽氟聚合物管
  • 為實現永續性目標，出現了環境友善、可生物分解的醫用導管材料。
  • 開發高軟性導管以增強心血管介入治療
  • 編織聚合物增強管材技術的進步提高了爆破壓力性能
  • 將智慧感測器整合到管道系統中，用於即時監測流量和壓力
  • 在門診環境中，可消毒的一次性管路組件越來越受到青睞。
  • 用於精密微流體診斷應用的薄壁微孔管創新
  • 滿足複雜解剖結構要求的3D列印客製化醫用導管的發展
  • 不斷完善的監管標準推動了可追溯和防篡改管路解決方案的普及。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用導管市場（依材料分類）

  • 聚乙烯
    • 高密度聚苯乙烯
    • 低密度聚乙烯
  • 聚氨酯
    • 熱塑性聚氨酯
    • 熱固性聚氨酯
  • 聚氯乙烯
    • 硬質PVC
    • 軟質PVC
  • 矽酮
    • 高黏度矽油
    • 液態矽油
  • 熱可塑性橡膠
    • 基於烯烴的熱塑性彈性體
    • 苯乙烯基熱塑性彈性體

9. 依最終用途分類的醫用導管市場

  • 導管
  • 牙科
  • 注射
    • 腸內輸注
    • 靜脈輸液
  • 侵入性的
    • 血管成形術
    • 支架輸送
  • 眼科

第10章 依製造流程分類的醫用導管市場

  • 擠壓
  • 模具

第11章 依產品類型分類的醫用導管市場

  • 導尿管
  • 擠壓管
    • 多流明
    • 單腔
  • 雷射焊接管

第12章 依最終用戶分類的醫用導管市場

  • 門診治療中心
  • 診所
  • 居家照護
  • 醫院

第13章 各地區的醫用導管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用導管市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫用導管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Freudenberg SE
    • Compagnie de Saint-Gobain SA
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • Terumo Corporation
    • Smiths Group plc
    • Fresenius SE & Co. KGaA
    • Teleflex Incorporated
    • Nipro Corporation
Product Code: MRR-BB6269D13429

The Medical Tubing Market is projected to grow by USD 19.33 billion at a CAGR of 12.18% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.70 billion
Estimated Year [2025] USD 8.63 billion
Forecast Year [2032] USD 19.33 billion
CAGR (%) 12.18%

Comprehensive introduction to the modern medical tubing landscape emphasizing clinical demand drivers, materials evolution, and cross-functional priorities

The medical tubing domain occupies a foundational role across a broad spectrum of clinical interventions, acting as both a technical enabler and a differentiator for device safety, usability, and therapeutic performance. Rising procedural volumes, heightened expectations for patient comfort, and the expansion of minimally invasive techniques have collectively intensified demand for tubing that balances flexibility, biocompatibility, and manufacturability. In parallel, the materials landscape is evolving rapidly: advances in polymer science are yielding blends and formulations that extend functional lifetimes, reduce thrombogenicity, and support novel bonding techniques, while novel surface treatments improve lubricity and drug elution potential. These materials advances intersect with manufacturing innovations, where precision extrusion and laser welding increasingly shape product form factors and tolerances.

Regulatory frameworks and clinical evidence requirements continue to exert substantial influence on product design and supplier selection, prompting manufacturers to invest in traceability, supplier qualification, and operations that meet stringent quality systems. At the same time, supply chain resilience has emerged as a board-level concern, driven by global disruptions and shifting trade policies. Consequently, strategic stakeholders must reconcile near-term operational imperatives with longer-term R&D commitments, ensuring tubing solutions remain aligned with clinician needs, patient safety, and cost-efficiency objectives. This introduction frames a sector in transition, where the convergence of clinical demand, material innovation, regulatory rigor, and supply chain strategy defines competitive advantage.

Analysis of the transformative shifts reshaping the medical tubing market including technological, regulatory, and clinical inflection points

The medical tubing market is undergoing a period of structural change driven by multiple converging forces. Technological advancements in polymer chemistry and processing have created tubing options with enhanced biocompatibility, improved mechanical properties, and better resistance to sterilization methods. These innovations enable thinner wall constructions, multi-lumen architectures, and laser-welded joins that support minimally invasive procedures and more complex device assemblies. At the same time, digitalization in manufacturing-ranging from inline quality inspection to data-driven process control-has improved reproducibility and reduced scrap, enabling manufacturers to meet stricter tolerances and accelerate time-to-market for new designs.

Regulatory expectations are also shifting toward greater transparency and post-market surveillance, prompting device makers and suppliers to invest in robust material characterization, batch traceability, and long-term biocompatibility testing. Clinical practice trends are driving material choice and tubing configurations: the rise of home care and ambulatory procedures increases demand for user-friendly, durable tubing, whereas growth in interventional cardiology and ophthalmology requires specialty materials with exceptional performance under complex mechanical stresses. Supply chain strategy has likewise adapted; firms are diversifying supplier bases and nearshoring select capabilities to mitigate geopolitical and logistical risk. Collectively, these transformative shifts are redefining product requirements and commercial models, favoring suppliers who combine material expertise, process discipline, and regulatory readiness.

Evaluation of the cumulative impact of United States tariffs announced in 2025 and their operational, sourcing, and strategic implications for medical tubing stakeholders

The tariff policy changes implemented in 2025 introduced a new variable for procurement, manufacturing, and commercialization strategies across the medical tubing value chain. For many manufacturers, tariffs altered the calculus of sourcing decisions by increasing landed costs for select imported polymer resins, specialty compounds, and finished components. In response, purchasing teams accelerated supplier qualification activities, prioritized alternative resin grades produced domestically or from tariff-exempt origins, and re-evaluated total cost of ownership rather than relying on unit price comparisons alone. These adjustments frequently required renegotiation of long-term supply agreements and a more granular analysis of duty engineering options.

Operationally, some firms adopted dual-sourcing strategies and increased onshore inventory buffers to reduce exposure to sudden cost shifts. Others invested in material substitution programs where clinically acceptable, substituting functionally equivalent polymers to avoid tariff-impacted supply lines while ensuring compliance with regulatory requirements. On the strategic front, tariffs prompted renewed focus on vertical integration and capacity expansion within tariff-favored jurisdictions, motivating capital allocation toward extrusion and molding assets closer to end markets. Simultaneously, the policy shift elevated the importance of regulatory harmonization and customs expertise, as complex classifications of medical tubing components influenced duty applicability. Overall, the cumulative effect of tariffs was to accelerate localization, diversify supply chains, and push manufacturers toward more resilient procurement architectures while maintaining clinical performance and compliance.

Key segmentation insights synthesizing material science, end use nuances, manufacturing approaches, product typologies, and end-user behavior to guide strategic focus

Material selection remains the principal determinant of tubing performance and regulatory pathway. The market spans Polyethylene, Polyurethane, Polyvinyl Chloride, Silicone, and Thermoplastic Elastomer, each offering specific trade-offs in flexibility, chemical resistance, and sterilization compatibility. Within Polyethylene, high density and low density grades provide distinct mechanical behavior and are chosen based on stiffness and processing needs. Polyurethane choices bifurcate into thermoplastic polyurethane and thermoset polyurethane, which differ in manufacturability and fatigue resistance. Polyvinyl Chloride options include rigid PVC for structural components and soft PVC for flexible applications, while silicone choices split between high consistency silicone and liquid silicone, each suited to different molding and extrusion requirements. Thermoplastic Elastomers present olefinic and styrenic families that balance elasticity with process throughput. Understanding these material distinctions is essential for aligning device requirements with manufacturability and lifecycle performance.

End use segmentation underscores clinical specificity, as catheter, dental, infusion, interventional, and ophthalmology applications demand tailored tubing properties. Infusion applications further distinguish between enteral and intravenous use, with each application imposing unique safety and compatibility constraints. Interventional categories such as angioplasty and stent delivery prioritize kink resistance, lubricity, and precise dimensional control. Manufacturing processes-principally extrusion and molding-drive design possibilities and cost structures, with extrusion enabling continuous multi-lumen profiles and molding accommodating complex connector geometries. Product type segmentation delineates catheter tubing, extruded tubing, and laser welded tubing; extruded tubing subdivides into multi-lumen and single lumen variants that influence device complexity and assembly. End user differences across ambulatory care centers, clinics, home care, and hospitals shape demand patterns, procurement practices, and service-level expectations. Integrating these segmentation lenses enables more precise product roadmaps, supplier selection, and commercialization strategies that reflect clinical performance requirements and operational realities.

Regional insights spotlighting differentiated demand drivers, regulatory environments, and supply chain strategies across major geographies to guide market entry and expansion

The Americas continue to emphasize cost-efficient manufacturing, high regulatory scrutiny, and a mature device market characterized by advanced clinical adoption and strong hospital purchasing power. In this region, reimbursement structures and centralized procurement can influence product commercialization timelines, while proximity to raw material producers and component suppliers supports complex assemblies and rapid prototyping. Manufacturers targeting the Americas typically prioritize regulatory dossier robustness and supply chain transparency to satisfy health system procurement processes.

Europe, Middle East & Africa present a diverse regulatory and market tapestry where harmonized standards coexist with local variances in reimbursement and clinical practice. European markets emphasize sustainability, extended product lifecycles, and rigorous clinical evidence, while certain Middle Eastern and African jurisdictions focus on affordability and supply chain continuity. Firms operating across this combined region benefit from modular regulatory strategies and scalable manufacturing footprints that can accommodate both high-complexity and cost-sensitive product variants.

Asia-Pacific demonstrates dynamic growth driven by expanding healthcare infrastructure, rising outpatient care, and a deepening manufacturing base for polymers and components. Localized supply chains, competitive labor costs, and increasing domestic demand encourage investments in regional production capacity and material innovation. However, infrastructure and regulatory maturity vary widely across countries, so successful strategies often combine export-focused operations with targeted local partnerships to address distinct clinical and procurement needs. Across all regions, firms are adapting strategies to balance proximity to customers, tariff exposure, and the need for regulatory conformity.

Critical company-level insights revealing competitive dynamics, innovation strategies, and supply chain positions that shape market leadership potential

Leading suppliers differentiate through deep materials expertise, extensive quality systems, and demonstrable regulatory track records. Firms that invest in application-specific R&D-translating polymer science into clinically relevant performance gains such as reduced thrombogenicity or enhanced kink resistance-tend to capture preference from device OEMs. Strategic partnerships between tubing specialists and device manufacturers accelerate co-development cycles and shorten validation timelines, enabling faster adoption of next-generation tubing solutions. Vertical integration is another axis of distinction; companies that control upstream compounding or downstream assembly can offer more competitive lead times and tighter cost control, which matters in environments impacted by tariff volatility and supply chain disruption.

Mergers, strategic acquisitions, and capacity investments have reshaped supplier landscapes, enabling certain companies to expand service portfolios from custom extrusion to complete tubing assemblies incorporating connectors and welded interfaces. Contract manufacturing organizations with specialized extrusion and laser welding capabilities offer flexible production models that appeal to mid-sized OEMs seeking to scale without heavy capital expenditure. Additionally, digital capabilities such as predictive maintenance, in-line inspection, and digital batch documentation strengthen supplier value propositions by reducing quality risk and accelerating regulatory submissions. Ultimately, competitive success hinges on aligning technological differentiation with scalable operations, regulatory competence, and customer-centric service models.

Actionable recommendations for industry leaders to strengthen innovation pipelines, secure supply continuity, and optimize regulatory and commercial pathways

Industry leaders should prioritize investments that simultaneously reduce operational risk and enable product differentiation. Strengthening supplier networks through tiered qualification programs and nearshoring selective capabilities can reduce exposure to tariff-driven cost volatility while maintaining access to specialized polymer grades. In parallel, accelerating material substitution initiatives-backed by rigorous validation protocols-can create flexibility to pivot away from constrained resin families without compromising clinical performance. From an innovation standpoint, cross-functional teams should align R&D with clinical stakeholders so tubing developments address real-world procedural challenges, such as smaller form factors for minimally invasive surgery or enhanced tactile feedback for interventional devices.

Leaders must also institutionalize regulatory foresight by embedding post-market surveillance and robust traceability into product lifecycles, thereby smoothing approvals and reinforcing customer trust. Commercial strategies should combine differentiated technical claims with service-level commitments like reduced lead times and configurable logistics, which are increasingly decisive in procurement decisions. Finally, firms should evaluate selective vertical integration or strategic partnerships to capture margin and control quality for mission-critical components, while leveraging contract manufacturers for scalable volume production. These combined actions will improve resilience, speed-to-market, and competitive positioning across diverse end-user channels.

Research methodology detailing a robust multi-source approach combining primary validation, materials analysis, manufacturing mapping, and regulatory review for reliable insights

Research methodology detailing a robust multi-source approach incorporating primary validation, materials analysis, manufacturing mapping, and regulatory review for reliable insights

The research approach combined structured primary interviews with senior procurement executives, R&D leaders, regulatory specialists, and clinical end users alongside a comprehensive review of technical literature, standards, and patent landscapes. Primary conversations provided real-world perspectives on material performance trade-offs, supplier selection criteria, and the operational effects of tariff policy changes. Materials analysis leveraged comparative evaluations of polymer properties, sterilization compatibilities, and manufacturability constraints to assess practical suitability across application types. Manufacturing mapping identified the capabilities and throughput characteristics of extrusion and molding processes, and highlighted where laser welding integrates into assembly flows.

Regulatory review focused on pathway considerations, biocompatibility testing expectations, and documentation practices that influence tubing qualification timelines. Findings were cross-validated through triangulation, aligning primary interview insights with technical sources and observable commercial activities, ensuring conclusions reflect both empirical practice and technological realities. Segmentation frameworks were applied to map material families, end uses, manufacturing processes, product types, and end-user channels to practical decision axes. Quality controls included peer review by domain experts and iterative validation with industry practitioners to ensure the research outputs are actionable, reproducible, and directly relevant to strategic decision-making.

Concluding synthesis that emphasizes strategic priorities, risk mitigation levers, and the imperative to align innovation with clinical and supply chain realities

In conclusion, the medical tubing landscape presents a nexus of opportunity and complexity where materials innovation, manufacturing precision, regulatory rigor, and shifting trade policies converge. Strategic advantage accrues to organizations that can integrate material science with disciplined manufacturing and regulatory readiness, while simultaneously insulating operations from geopolitical and tariff-related volatility. The most successful players will be those who translate clinical insights into targeted tubing functionalities, back those innovations with validated supply chains, and present compelling total cost and service propositions to end users.

Risk mitigation through diversified sourcing, material flexibility, and investment in near-term manufacturing resilience will be essential to maintain continuity under evolving policy environments. At the same time, sustained competitiveness requires ongoing R&D to address clinician-driven performance requirements and evolving sterilization and biocompatibility standards. By prioritizing these strategic levers, stakeholders can navigate short-term disruption while building the foundational capabilities needed to capture long-term value in a market increasingly defined by precision, reliability, and clinical relevance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Customizable biocompatible polymer tubing for patient-specific infusion needs
  • 5.2. Integration of antimicrobial coatings in medical tubing to reduce hospital infections
  • 5.3. Demand growth for kink-resistant multi-lumen tubing in advanced surgical procedures
  • 5.4. Adoption of silicone-free fluoropolymer tubing for improved chemical inertness in drug delivery
  • 5.5. Emergence of eco-friendly biodegradable medical tubing materials to meet sustainability goals
  • 5.6. Development of high-flexibility catheter tubing for enhanced cardiovascular interventions
  • 5.7. Advances in braided polymer-reinforced tubing for increased burst pressure performance
  • 5.8. Integration of smart sensors in tubing systems for real-time monitoring of flow and pressure
  • 5.9. Rising preference for sterilizable single-use tubing assemblies in outpatient care settings
  • 5.10. Innovations in thin-walled microbore tubing for precise microfluidic diagnostic applications
  • 5.11. Growth of 3D-printed customized medical tubing for complex anatomical requirements
  • 5.12. Expansion of regulatory standards driving adoption of traceable, tamper-evident tubing solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Tubing Market, by Material

  • 8.1. Polyethylene
    • 8.1.1. High Density Polyethylene
    • 8.1.2. Low Density Polyethylene
  • 8.2. Polyurethane
    • 8.2.1. Thermoplastic Polyurethane
    • 8.2.2. Thermoset Polyurethane
  • 8.3. Polyvinyl Chloride
    • 8.3.1. Rigid PVC
    • 8.3.2. Soft PVC
  • 8.4. Silicone
    • 8.4.1. High Consistency Silicone
    • 8.4.2. Liquid Silicone
  • 8.5. Thermoplastic Elastomer
    • 8.5.1. Olefinic TPE
    • 8.5.2. Styrenic TPE

9. Medical Tubing Market, by End Use

  • 9.1. Catheter
  • 9.2. Dental
  • 9.3. Infusion
    • 9.3.1. Enteral Infusion
    • 9.3.2. Intravenous Infusion
  • 9.4. Interventional
    • 9.4.1. Angioplasty
    • 9.4.2. Stent Delivery
  • 9.5. Ophthalmology

10. Medical Tubing Market, by Manufacturing Process

  • 10.1. Extrusion
  • 10.2. Molding

11. Medical Tubing Market, by Product Type

  • 11.1. Catheter Tubing
  • 11.2. Extruded Tubing
    • 11.2.1. Multi Lumen
    • 11.2.2. Single Lumen
  • 11.3. Laser Welded Tubing

12. Medical Tubing Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Home Care
  • 12.4. Hospitals

13. Medical Tubing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Tubing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Tubing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Freudenberg SE
    • 16.3.2. Compagnie de Saint-Gobain S.A.
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. Becton, Dickinson and Company
    • 16.3.5. Baxter International Inc.
    • 16.3.6. Terumo Corporation
    • 16.3.7. Smiths Group plc
    • 16.3.8. Fresenius SE & Co. KGaA
    • 16.3.9. Teleflex Incorporated
    • 16.3.10. Nipro Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL TUBING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL TUBING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL TUBING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MEDICAL TUBING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MEDICAL TUBING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MEDICAL TUBING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL TUBING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL TUBING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL TUBING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL TUBING MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL TUBING MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL TUBING MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL TUBING MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL TUBING MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL TUBING MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOSET POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOSET POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOSET POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOSET POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOSET POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOSET POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL TUBING MARKET SIZE, BY RIGID PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL TUBING MARKET SIZE, BY RIGID PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL TUBING MARKET SIZE, BY RIGID PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL TUBING MARKET SIZE, BY RIGID PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL TUBING MARKET SIZE, BY RIGID PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL TUBING MARKET SIZE, BY RIGID PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL TUBING MARKET SIZE, BY SOFT PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL TUBING MARKET SIZE, BY SOFT PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL TUBING MARKET SIZE, BY SOFT PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL TUBING MARKET SIZE, BY SOFT PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL TUBING MARKET SIZE, BY SOFT PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL TUBING MARKET SIZE, BY SOFT PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL TUBING MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL TUBING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL TUBING MARKET SIZE, BY LIQUID SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL TUBING MARKET SIZE, BY LIQUID SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL TUBING MARKET SIZE, BY LIQUID SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL TUBING MARKET SIZE, BY LIQUID SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL TUBING MARKET SIZE, BY LIQUID SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL TUBING MARKET SIZE, BY LIQUID SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL TUBING MARKET SIZE, BY OLEFINIC TPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL TUBING MARKET SIZE, BY OLEFINIC TPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL TUBING MARKET SIZE, BY OLEFINIC TPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL TUBING MARKET SIZE, BY OLEFINIC TPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL TUBING MARKET SIZE, BY OLEFINIC TPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL TUBING MARKET SIZE, BY OLEFINIC TPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL TUBING MARKET SIZE, BY STYRENIC TPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL TUBING MARKET SIZE, BY STYRENIC TPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL TUBING MARKET SIZE, BY STYRENIC TPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL TUBING MARKET SIZE, BY STYRENIC TPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL TUBING MARKET SIZE, BY STYRENIC TPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL TUBING MARKET SIZE, BY STYRENIC TPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL TUBING MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL TUBING MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL TUBING MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL TUBING MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL TUBING MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL TUBING MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL TUBING MARKET SIZE, BY INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL TUBING MARKET SIZE, BY ENTERAL INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL TUBING MARKET SIZE, BY ENTERAL INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL TUBING MARKET SIZE, BY ENTERAL INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL TUBING MARKET SIZE, BY ENTERAL INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL TUBING MARKET SIZE, BY ENTERAL INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL TUBING MARKET SIZE, BY ENTERAL INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTRAVENOUS INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTRAVENOUS INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTRAVENOUS INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTRAVENOUS INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL TUBING MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL TUBING MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL TUBING MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL TUBING MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL TUBING MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL TUBING MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL TUBING MARKET SIZE, BY STENT DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL TUBING MARKET SIZE, BY STENT DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL TUBING MARKET SIZE, BY STENT DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL TUBING MARKET SIZE, BY STENT DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL TUBING MARKET SIZE, BY STENT DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL TUBING MARKET SIZE, BY STENT DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL TUBING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL TUBING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL TUBING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL TUBING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL TUBING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL TUBING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL TUBING MARKET SIZE, BY MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL TUBING MARKET SIZE, BY MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL TUBING MARKET SIZE, BY MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL TUBING MARKET SIZE, BY MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL TUBING MARKET SIZE, BY MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL TUBING MARKET SIZE, BY MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL TUBING MARKET SIZE, BY CATHETER TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL TUBING MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL TUBING MARKET SIZE, BY MULTI LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL TUBING MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL TUBING MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL TUBING MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL TUBING MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL TUBING MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL TUBING MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL TUBING MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL TUBING MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL TUBING MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL TUBING MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL TUBING MARKET SIZE, BY LASER WELDED TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL TUBING MARKET SIZE, BY LASER WELDED TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL TUBING MARKET SIZE, BY LASER WELDED TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL TUBING MARKET SIZE, BY LASER WELDED TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL TUBING MARKET SIZE, BY LASER WELDED TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL TUBING MARKET SIZE, BY LASER WELDED TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL TUBING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL TUBING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL TUBING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL TUBING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL TUBING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL TUBING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL TUBING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL TUBING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL TUBING MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL TUBING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL TUBING MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL TUBING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL TUBING MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL TUBING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL TUBING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL TUBING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS MEDICAL TUBING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS MEDICAL TUBING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS MEDICAL TUBING MARKET SIZE, BY SILICONE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS MEDICAL TUBING MARKET SIZE, BY SILICONE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS MEDICAL TUBING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS MEDICAL TUBING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS MEDICAL TUBING MARKET SIZE, BY INFUSION, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS MEDICAL TUBING MARKET SIZE, BY INFUSION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS MEDICAL TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS MEDICAL TUBING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY SILICONE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY SILICONE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY INFUSION, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY INFUSION, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA MEDICAL TUBING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY SILICONE, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY SILICONE, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY INFUSION, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY INFUSION, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY INTERVENTIONAL, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY EXTRUDED TUBING, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA MEDICAL TUBING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY POLYURETHANE, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY POLYVINYL CHLORIDE, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY SILICONE, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA MEDICAL TUBING MARKET SIZE, BY SILICONE, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA MEDIC